JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: '4 hqn'

Search results for: '4 hqn'

A1196 SGX-523
1 Citation

Target: MET

Summary: MET inibitor, highly selective, ATP-competitive

≥17.95 mg/mL
A5092 JNJ-38877605

Summary: C-Met inhibitor,ATP-competitive

insoluble in H2O; ≥18.85 mg/mL
B1523 PF-573228
1 Citation

Summary: ATP-competitive FAK inhibitor

insoluble in EtOH; insoluble in H2O; ≥166.6 mg/mL
A3449 GSK343
1 Citation

Target: EZH2

Summary: EZH2 inhibitor,potent,selective and cell permeable
A1877 XAV-939
1 Citation

Target: TNKS

Summary: Tankyrase 1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A4385 Ganetespib (STA-9090)
3 Citation

Summary: Hsp90 inhibitor,non-geldanamycin

insoluble in H2O; ≥18.22 mg/mL
BA2884 Tegaserod

Summary: Tegaserod is an orally effective 5-hydroxytryptamine receptor 4(;) agonist and receptor antagonist.
BA8090 5MPN

Summary: 5MPN is a first-in-class, orally active and selective inhibitor of fructose-6-phosphate-2 kinase/fructose-2,6-bisphosphatase 4.
BA8211 Lirimilast

Summary: Lirimilast (BAY19-8004) is a potent, selective and orally active phosphodiesterase 4 inhibitor.
BA5210 TM38837

Summary: 4 (TM38837) is an inverse agonist of cannabinoid receptor 1 is 0.4 nM.